Objective To evaluate the efficacy of pap smear, HPV DNA testing and colposcopy and to determine the approach for cervical cancer screening in low resource settings. Methods Eight hundred non pregnant married women above 30 years of age were studied and subjected to pap smear examination. Hysterectomised women were excluded from the study. Selected patients were followed by HPV DNA testing by Hybrid Capture II method, colposcopy and biopsy. Sensitivity, specificity, Positive predictive value (PPV), Negative predictive value (NPV), diagnostic accuracy and kappa value (k) were calculated for each screening test. Result Out of eight hundred women with mean age 36.5 ± 5.94 years undergoing pap smear, ASCUS was found in 66(8.25%), ASC-H in 2(0.25%), LSIL in 48(6%), HSIL in 8(1%), inflammatory in 540(67.5%). Out of 260 women who underwent HPV DNA testing, 120 (46.15%) had abnormal cytology and/or positive HPV DNA test (Group I, n = 120) and 140(53.8%) had dual negative results (Group II, n = 140) HPV DNA test was found positive in 64 women (53.3%) in Group I. Sensitivity and specificity of pap smear was 69.2 and 63.72% while for HPV DNA testing was 92.3 and 84% respectively. PPV and NPV of pap smear, HPV DNA testing and colposcopy was 18, 40, 76.4% and 94.7, 98.9, 100% respectively. Diagnostic accuracy of pap smear (k = 0.14), HPV DNA test (k = 0.70) and colposcopy (k = 0.81) was 64.29, 84.9, and 96.8% respectively. Combining pap smear & HPV DNA testing (k = 0.25) increased the sensitivity and NPV to 100%. Conclusion Sensitivity and diagnostic accuracy of HPV DNA test is more than that of pap smear and the test is not influenced by inflammatory conditions of vagina. In low resource settings, women with ASCUS and LSIL on cervical cytology should be subjected to HPV DNA test and only if found positive should be referred for colposcopy thereby reducing colposcopy referrals. Women with HSIL should be directly subjected to colposcopy guided biopsy. Using this approach, most of the preinvasive cervical lesion will be detected but few cases will still be missed among inflammatory smears, if HPV DNA testing is not supplemented.
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Introduction
In developing countries, cancer cervix is the most common genital malignancy accounting for 80% of all world cases, 16% cases are from India. Infection with high risk Human Papilloma virus (HR-HPV) is the major risk factor for the development of cervical cancer. HPV is highly prevalent among sexually active persons and traceable in its natural history with technology that can detect HPV DNA. HPV testing is being evaluated as a potential alternative or adjunctive to cervical cytology for early detection of cervical cancer precursors. This study was done to compare the diagnostic accuracy of pap smear, HPV DNA test by Hybrid Capture II method and colposcopy and to determine an approach for cervical cancer screening that can be used in low resource settings.
Material and Method
Eight hundred non pregnant married women above 30 years of age were enrolled in the study. A detailed history was taken followed by gynecological examination. Hysterctomised women were excluded from the study. Women with clinically apparent vaginitis were first treated and then subjected to study. Four hundred women were subjected to pap smear examination. Out of 800, 260 women underwent HPV DNA testing by HC-II method. Colposcopy was done in women with abnormal cytology and/or a positive high risk HPV DNA test and in a randomly selected sample of 10% women with negative findings on both test. Biopsy was done if colposcopy was found suspicious. Sensitivity, specificity, Positive predictive value (PPV), negative predictive value (NPV), diagnostic accuracy and kappa value (k) were calculated for each screening test.
Results
Out of eight hundred women with mean age 36.5 ± 5.94 years undergoing pap smear examination, 124 had abnormal cytology. ASCUS was found in 66(8.25%), ASC-H in 2 (0.25%), LSIL in 48(6%), HSIL in 8(1%) and inflammatory in 540 (67.5%) ( Table 1 ). Fifty (6.25%) smears were reported as unsatisfactory. Out of 260 women who underwent HPV DNA testing, 120(46.15%) had abnormal cytology and/or positive HPV DNA test (Group I, n = 120) and 140(53.8%) had dual negative results (Group II, n = 140) ( Table 2 ). HPV DNA test was found positive in 64 women (53.3%) in group I. Sensitivity and specificity of pap smear was 69.2 and 63.72% while for HPV DNA testing was 92.3 and 84% respectively. PPV of pap smear was low 18% as compared to 40% of HPV DNA testing. Negative predictive value of pap smear was 94.7% and that of HPV DNA test was 98.9%. Sensitivity and negative predictive value of combined pap smear and HPV DNA test increased to 100%. Biopsy results showed 4 cases of cervicitis, 10 cases of CIN1, 4 cases of CIN 3 and 2 cases of squamous cell carcinoma. The sensitivity of colposcopy was found to be highest 100%. The PPV and negative predictive value of colposcopy was 76.4 and 100% respectively. Diagnostic accuracy of pap smear was 64.29% and k was 0.14 which was in slight agreement with histology. Diagnostic accuracy of HPV DNA test was found to be 84.9% and its kappa value (K = 0.70) was in substantial agreement with histology. Diagnostic accuracy of colposcopy was found to be highest 96.8% and its kappa value (k = 0.81) was in perfect agreement with histology. Combining pap smear and HPV DNA testing increased the sensitivity and negative predictive value to 100% and its kappa value (k = 0.25) was in fair agreement with histology (Table 3) .
Discussion
The present study showed the sensitivity of HPV DNA test for diagnosing CIN was 92.3%, specificity 84% and high negative predictive value of 98.9%. Lin et al. [1] and Clavel et al. [2] showed the sensitivity of HPV DNA test to be 100%. Petry et al. [3] calculated test characteristics of HPV DNA test for histologically confirmed CIN3 only and found 100% negative predictive value. Kappa value calculated for HPV DNA test was 0.70 in the present study which is similar to that of the study of Kumar et al. [5] who found kappa value to be 0.67. Ratnam et al. [4] found sensitivity of pap smear 45% and specificity 64% which is similar to present study. Clavel et al. [2] and Kumar et al. [5] found sensitivity of combined pap and HPV DNA test 93.3% and negative predictive value of combined test to be 98.8% which is similar to our study. HPV testing in conjunction with cytology improves the screening efficacy of cytology alone and may allow for a more effective and safe primary screening programme with increased screening interval. 
